Agrima Mian

641 total citations
36 papers, 248 citations indexed

About

Agrima Mian is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Agrima Mian has authored 36 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 10 papers in Pathology and Forensic Medicine and 5 papers in Genetics. Recurrent topics in Agrima Mian's work include CAR-T cell therapy research (19 papers), Lymphoma Diagnosis and Treatment (10 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Agrima Mian is often cited by papers focused on CAR-T cell therapy research (19 papers), Lymphoma Diagnosis and Treatment (10 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Agrima Mian collaborates with scholars based in United States, India and Canada. Agrima Mian's co-authors include Brian T. Hill, Achintya D. Singh, Nathan Denlinger, Deborah M. Stephens, Sarah Nagle, Alexey V. Danilov, Max J. Gordon, Lindsey Fitzgerald, Brad Pohlman and Adam S. Kittai and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Agrima Mian

29 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Agrima Mian United States 8 151 47 41 34 33 36 248
Siddharth Bhattacharyya United States 6 139 0.9× 31 0.7× 20 0.5× 26 0.8× 70 2.1× 15 239
David Beauvais France 10 168 1.1× 95 2.0× 26 0.6× 20 0.6× 16 0.5× 39 329
Joseph Maakaron United States 12 251 1.7× 79 1.7× 35 0.9× 30 0.9× 38 1.2× 65 465
Clint Divine United States 8 180 1.2× 39 0.8× 28 0.7× 12 0.4× 20 0.6× 16 259
Chu Ri Shin United States 6 114 0.8× 49 1.0× 29 0.7× 41 1.2× 15 0.5× 13 299
Efrat Luttwak Israel 10 183 1.2× 34 0.7× 23 0.6× 46 1.4× 45 1.4× 29 330
Forat Lutfi United States 10 194 1.3× 39 0.8× 34 0.8× 5 0.1× 17 0.5× 49 257
Ali Bukhari United States 9 206 1.4× 45 1.0× 44 1.1× 14 0.4× 70 2.1× 25 297
David M. Cordas dos Santos Germany 8 251 1.7× 82 1.7× 32 0.8× 7 0.2× 25 0.8× 16 304
Karthik Nath Australia 8 146 1.0× 48 1.0× 28 0.7× 5 0.1× 45 1.4× 31 256

Countries citing papers authored by Agrima Mian

Since Specialization
Citations

This map shows the geographic impact of Agrima Mian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agrima Mian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agrima Mian more than expected).

Fields of papers citing papers by Agrima Mian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agrima Mian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agrima Mian. The network helps show where Agrima Mian may publish in the future.

Co-authorship network of co-authors of Agrima Mian

This figure shows the co-authorship network connecting the top 25 collaborators of Agrima Mian. A scholar is included among the top collaborators of Agrima Mian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agrima Mian. Agrima Mian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Kirkpatrick, R. L., Joanne C. Beer, Agrima Mian, et al.. (2024). Abstract 3867: Identification of novel biomarkers of immune toxicity from CAR T-cell therapy using ultrasensitive NULISA™ proteome technology. Cancer Research. 84(6_Supplement). 3867–3867. 1 indexed citations
4.
Zhao, Qiuhong, Agrima Mian, Chenyu Lin, et al.. (2023). Efficacy of Siltuximab for Chimeric Antigen Receptor T-Cell Therapy Toxicities - a Multicenter Retrospective Analysis. Blood. 142(Supplement 1). 4502–4502. 5 indexed citations
5.
Mian, Agrima, Syed Arsalan Ahmed Naqvi, Muhammad Husnain, et al.. (2023). Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: A systematic review and meta-analysis. Leukemia Research. 131. 107324–107324. 7 indexed citations
6.
Hershberger, Courtney E., et al.. (2022). Host metabolome predicts the severity and onset of acute toxicities induced by CAR T-cell therapy. Blood Advances. 7(17). 4690–4700. 3 indexed citations
7.
Mian, Agrima, Wei Wei, Brian T. Hill, et al.. (2021). Resource Utilization and Factors Prolonging Hospitalization for Patients with Refractory and Relapsed Large B-Cell Lymphoma Receiving Tisagenlecleucel Versus Axicabtagene Ciloleucel. Transplantation and Cellular Therapy. 27(3). S307–S307. 2 indexed citations
8.
9.
Singh, Achintya D., Agrima Mian, & James K. Stoller. (2021). Is it safe to start steroids at home for a COPD exacerbation after virtual assessment in the COVID-19 era?. Cleveland Clinic Journal of Medicine. 88(4). 213–215.
10.
Shouse, Geoffrey, Andy Kaempf, Audrey M. Sigmund, et al.. (2021). Impact of Comorbidities on Outcomes and Toxicity in Patients Treated with CAR T-Cell Therapy for Diffuse Large B Cell Lymphoma (DLBCL): A Multicenter Rwe Study. Blood. 138(Supplement 1). 529–529. 4 indexed citations
11.
Ganguly, Shuvadeep, Deepam Pushpam, Agrima Mian, et al.. (2020). Real-world Experience of Imatinib in Pediatric Chronic Phase Chronic Myeloid Leukemia: A Single-center Experience From India. Clinical Lymphoma Myeloma & Leukemia. 20(7). e437–e444. 9 indexed citations
12.
13.
Singh, Achintya D., Agrima Mian, Niveditha Devasenapathy, Gordon Guyatt, & Ganesan Karthikeyan. (2020). Percutaneous mitral commissurotomy versus surgical commissurotomy for rheumatic mitral stenosis: a systematic review and meta-analysis of randomised controlled trials. Heart. 106(14). 1094–1101. 5 indexed citations
14.
Kittai, Adam S., Ying Huang, Max J. Gordon, et al.. (2020). Comorbidities Predict Inferior Survival in Patients Receiving Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma: A Multicenter Analysis. Transplantation and Cellular Therapy. 27(1). 46–52. 37 indexed citations
15.
16.
Ondrejka, Sarah L., Agrima Mian, Yazeed Sawalha, et al.. (2020). Gene Expression and Epigenetic Analysis in Relapsed/Refractory Diffuse Large B Cell Lymphoma Provides Insights into Evolution of Treatment Resistance to R-CHOP. Blood. 136(Supplement 1). 26–26. 2 indexed citations
17.
18.
Mian, Agrima, Wei Wei, Allison Winter, et al.. (2019). Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat Analysis. Blood. 134(Supplement_1). 4452–4452. 5 indexed citations
19.
Mian, Agrima, Wei Wei, Rajshekhar Chakraborty, et al.. (2019). Survival Outcomes in Patients with Waldenström Macroglobulinemia/ Lymphoplasmacytic Lymphoma According to MYD88 Mutation Status. Blood. 134(Supplement_1). 5248–5248. 1 indexed citations
20.
Mian, Agrima & Animesh Ray. (2018). Thoracic sarcoidosis versus tuberculosis: Need for a multi-disciplinary approach. Indian journal of radiology and imaging - new series/Indian journal of radiology and imaging/Indian Journal of Radiology & Imaging. 28(2). 267–268. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Siddharth Bhattacharyya Breakdown of academic impact, for papers by David Beauvais Breakdown of academic impact, for papers by Joseph Maakaron Breakdown of academic impact, for papers by Clint Divine Breakdown of academic impact, for papers by Chu Ri Shin Breakdown of academic impact, for papers by Efrat Luttwak Breakdown of academic impact, for papers by Forat Lutfi Breakdown of academic impact, for papers by Ali Bukhari Breakdown of academic impact, for papers by David M. Cordas dos Santos Breakdown of academic impact, for papers by Karthik Nath
Rankless by CCL
2026